Platform ReviewUpdated 2026-05-06

Burford Capital

NYSE- and LSE-listed equity proxy for commercial litigation finance — $7.5B portfolio, 83% cumulative ROIC, 26% IRR on concluded matters — but the March 2026 YPF Second Circuit reversal and an unremediated internal control weakness are the two facts every investor needs to sit with before buying.

Legal Claims — Commercial Litigation & ArbitrationLitigation Finance Public Company
Burford Capital platform screenshot

What the data actually shows - TL;DR

Burford is the most credible public-equity proxy for commercial litigation finance. The 15-year track record — 83% cumulative ROIC and 26% IRR on concluded matters across roughly $3.8B in lifetime realizations — is real, audited (KPMG as of July 2024), and hard for any private platform to match on scale. The structural risks are also real: fair value accounting creates quarterly earnings that bear little resemblance to cash generation, YPF-related assets represent 46% of the portfolio after the March 2026 Second Circuit reversal introduced a material headwind, and an internal control weakness over fair value measurement was unremediated as of December 31, 2024. BUR is a long-term equity position for investors who understand what they are buying — a leveraged, long-duration, opaque underwriting business that happens to trade on a stock exchange.

83% / 26%Cumulative ROIC / IRR on concluded capital provision-direct matters since inception per company disclosure. FY2024 concluded matters: ROIC 87%, IRR 26%. FY2025: ROIC 83%, IRR 26%. Strong and consistent but concentrated in specific vintages and outsized wins.
$7.5BTotal group-wide portfolio as of FY2025. Portfolio base $2.85B. $872M new definitive commitments in FY2025. $710.5M realizations (down from $907M in FY2024). Liquidity $621M.
46%YPF-related assets as percentage of capital provision assets as of December 31, 2025 — up from 42% in FY2024. March 27, 2026 Second Circuit reversal materially impacted the fair value of these assets in Q1 2026, not reflected in FY2025 financials.
UnremediatedMaterial weakness in internal controls over fair value measurement of capital provision assets — first disclosed in FY2023 20-F, still unremediated as of December 31, 2024 per FY2024 10-K. Auditor changed from EY to KPMG on July 1, 2024.
$0.125Annual dividend per share (semi-annual cadence, $0.0625 per payment) — consistent across FY2022, FY2023, FY2024, FY2025. Total annual dividends approximately $27M. Not a yield vehicle — treat as total-return equity.

AltStreet tracks FY2022–FY2025 annual performance history for Burford Capital from primary 10-K filings via ingestPublicFilings.ts. One EDGAR exit record: Burford Alternative Income Fund II LP ($303M, 7 institutional investors, 506(b), May 2022). Six pre-open Burford fund entities confirmed at $0 Reg D capital — institutional capital raised outside Reg D.

AltStreet Weekly

Get new platform breakdowns weekly

One useful review, data point, or platform comparison each week. Built for investors who want the answer and the evidence.

No spam. Just alternative-investment research when it is useful.

Subscribe free

Quick Verdict

Is this platform right for you?

Burford is a legitimate institutional-quality business with a 15-year track record that no retail-accessible litigation finance platform can match. The public listing provides daily liquidity, SEC-audited financials, and diversification across 100+ active matters. The risks are specific and material: YPF concentration at 46% of portfolio creates binary event risk, the unremediated ICFR weakness raises questions about fair value precision, and the 7.5% coupon on recent debt issuances reflects real leverage risk. Sophisticated long-term investors seeking liquid alternative asset exposure will find BUR the most credible entry point in the category. Short-term traders, income seekers, and investors who cannot tolerate quarterly fair-value earnings volatility should look elsewhere.

Best for

  • Sophisticated long-term equity investors (5–7 year horizon) seeking alternative asset exposure through a liquid public security without private fund lockups
  • Alternatives allocators who want diversified commercial litigation finance exposure across 100+ matters managed by a 45+ lawyer institutional team
  • Investors comfortable with fair value accounting mechanics and willing to evaluate BUR on cumulative cash realizations rather than quarterly GAAP earnings
  • Taxable account holders seeking qualified dividend treatment and long-term capital gains on stock appreciation

Avoid if

  • You need quarterly income predictability — fair value accounting creates earnings volatility entirely unrelated to cash generation
  • You want case-level transparency or the ability to select specific litigation investments — public shareholders have no visibility into individual underwriting decisions
  • You are evaluating BUR as a lower-risk alternative to private litigation finance — the YPF concentration and ICFR weakness mean this is not a low-risk position
  • You have a horizon shorter than 3–5 years — case realization timing is inherently unpredictable and stock price may not reflect underlying value in the short term

Top strengths

  • 15-year track record with 83% cumulative ROIC and 26% IRR on concluded matters — the most credible public performance history in commercial litigation finance
  • NYSE/LSE listing provides daily liquidity, SEC-audited financials, and regulated disclosure — structural advantages over private litigation finance alternatives
  • 93% recovery rate on concluded matters by deployed capital demonstrates consistent underwriting quality across 15+ years and multiple market cycles
  • Scale ($7.5B portfolio, 45+ in-house lawyers, 160+ employees) creates origination, underwriting, and enforcement capabilities no retail platform can replicate

Key limitations

  • YPF-related assets at 46% of capital provision portfolio create dangerous single-case concentration — March 2026 Second Circuit reversal is a material Q1 2026 headwind
  • Unremediated material weakness in internal controls over fair value measurement of capital provision assets (disclosed FY2023, unresolved FY2024) creates independent verification concerns
  • Fair value accounting produces quarterly earnings that bear no predictable relationship to cash generation — sophisticated understanding required to avoid misinterpreting results
  • 7.5% coupon on July 2025 senior notes reflects real leverage and refinancing risk; net debt at 22% of tangible assets creates meaningful sensitivity to capital markets conditions

Why It Matters

Investor relevance and market role

Burford matters because it is the only liquid public-equity proxy for institutional-scale commercial litigation finance. If you want broad exposure to the asset class without committing to a private fund or underwriting individual claims, BUR is the clearest route. The LexShares experience — marketed 47% IRR, approximately 4% actual fund-level trajectory — demonstrates why retail investors need institutional-grade underwriting and diversification. Burford provides both, at the cost of fair value accounting volatility and case concentration risk.

Type

Public equity proxy for litigation finance

How To Invest

Buy common stock on NYSE: BUR or LSE: BUR

Exposure

Diversified commercial legal-claims underwriting, not direct case ownership

Minimum

None — public stock

Eligibility

Anyone with a brokerage account

Liquidity

Daily exchange trading — no lockup

Tax Document

1099-DIV (dividends), Schedule D (gains)

Dividend

$0.125/share annually (semi-annual)

Real-world validation

  • 15-year SEC-audited track record with 83% cumulative ROIC and 26% IRR on concluded matters — independently verified through KPMG audit
  • NYSE/LSE listing with quarterly 10-K/10-Q reporting — highest transparency standard in the litigation finance category
  • AltStreet FY2022–FY2025 performance history extracted from primary 10-K filings — realizations, revenue, net income, balance sheet verified from primary sources
  • EDGAR Form D for Alternative Income Fund II LP confirms $303M institutional raise from 7 investors in May 2022 — validates institutional demand for Burford private fund products

Scale signals

Total Portfolio

$7.5B

Group-wide total commitments as of FY2025

Lifetime Realizations

~$3.8B

Cumulative cash received from concluded matters since inception

Active Matters

227+

Balance sheet-funded assets as of December 31, 2024 (plus 9 Advantage Fund assets)

Recovery Rate

93%

Percentage of concluded matters by deployed capital generating recoveries

Quick Answers

What most investors want to know first

The highest-signal facts first: minimums, liquidity reality, K-1 timing, and whether distributions are actually part of the experience.

Liquidity

Full secondary market liquidity via NYSE and LSE. No proprietary redemption mechanism. Stock price may diverge from intrinsic value for extended periods — 2019 Muddy Waters short-seller attack crashed stock before recovery is the canonical example. YPF reversal creates near-term price uncertainty.

K-1 Timing

No K-1 expected for standard brokerage ownership of Burford common stock. US holders receive Form 1099-DIV, typically late-January to mid-February.

Distributions

Paid through brokerage account on standard public-equity payable dates. FY2025 example: interim dividend paid December 4, 2025; proposed final dividend record date May 22, 2026, pay date June 12, 2026.

Overview

Platform Overview

A concise read on what the platform is, how the structure works, and where the practical friction shows up for real investors.

Litigation finance provider funding commercial legal disputes globally through two primary models: (1) single-case financing providing capital to corporations or law firms to fund lawsuit costs in exchange for percentage of recoveries, and (2) portfolio financing bundling capital across multiple matters. Burford operates as a publicly traded company (NYSE/LSE: BUR) incorporated in Guernsey with operational headquarters at 350 Madison Avenue, New York. Business segments: Principal Finance (core balance-sheet litigation financing, renamed from Capital Provision in FY2024) and Asset Management and Other Services (managing third-party capital through private funds). Typical clients: Fortune 500 companies and AmLaw/Global 100 law firms seeking to monetize claims, shift litigation risk, or finance high-stakes disputes. Underwriting conducted in-house by 45+ lawyer team. Focus on commercial disputes with $10M+ claim values. Historical performance since inception: ~$3.8B lifetime realizations, ~83% cumulative ROIC, ~26% IRR on concluded matters. Portfolio scale FY2025: $7.5B total commitments, 93% recovery rate by deployed capital. EDGAR: Burford Capital Ltd (CIK 0001714174) is the public filer. Burford Capital LLC (CIK 0001714257) files annual Form D for nonqualified deferred compensation plan — not an investor offering. Burford Alternative Income Fund II LP (CIK 0001930272) raised $303M from 7 institutional investors via 506(b) in May 2022. Six additional Burford fund entities (Opportunity Fund LP/B LP, Feeder Fund, Employee Feeder Fund, Alternative Income Fund LP, Feeder) all pre-open at $0 Reg D — institutional capital raised outside Reg D requirements.

Founded in 2009 by Christopher Bogart (former Time Warner GC) and Jonathan Molot (Georgetown Law professor), the company has built a 15-year track record with approximately $3.8B in lifetime realizations and 83% cumulative ROIC on concluded matters. FY2025 portfolio scale: $7.5B total commitments, $2.85B portfolio base, $872M new definitive commitments, $710.5M realizations, $621M liquidity. The business generates returns through fair-value accounting on litigation portfolio assets quarterly, with actual cash received when cases resolve. FY2024 realizations of $907M and FY2025 realizations of $710.5M reflect the lumpy, case-driven nature of the business. The most material near-term risk is YPF concentration — 46% of capital provision assets are YPF-related as of December 31, 2025, and the March 27, 2026 Second Circuit reversal in the YPF nationalization case creates a material Q1 2026 fair value headwind not reflected in FY2025 financials. The unremediated ICFR material weakness (FY2023 origin, unresolved FY2024) and the July 2024 auditor change from EY to KPMG are governance factors requiring investor awareness. Dividend policy: $0.125/share annually (semi-annual cadence), consistent FY2022–FY2025.

Founded

2009 by Christopher Bogart and Jonathan Molot

Listings

NYSE: BUR, LSE: BUR. Transitioned to US domestic issuer status January 1, 2025

Headquarters

Guernsey (incorporated) / New York, 350 Madison Avenue (operational)

SEC CIK

0001714174

Regulatory Status

SEC-registered public company. 10-K/10-Q filer as of FY2024.

Auditor

KPMG LLP (from July 1, 2024; previously Ernst & Young LLP)

Portfolio Scale (FY2025)

$7.5B total group-wide portfolio, $2.85B portfolio base

FY2025 Realizations

$710.5M (FY2024: $907M, FY2023: $708.3M)

Concluded Matters ROIC

83% (FY2025), 87% (FY2024) — cumulative since inception

Concluded Matters IRR

26% (FY2024 and FY2025) — cumulative since inception

Lifetime Realizations

~$3.8B since inception per FY2025 disclosure

Recovery Rate

93% of concluded matters by deployed capital

YPF Concentration

46% of capital provision assets as of December 31, 2025

YPF Headwind

March 27, 2026 Second Circuit reversal — Q1 2026 fair value impact not yet disclosed

Material Weakness

Unremediated ICFR weakness over fair value measurement (disclosed FY2023, unresolved FY2024)

Annual Dividend

$0.125/share (semi-annual, $0.0625 per payment) — FY2022 through FY2025

Total Debt (FY2024)

$1.763B including $675M 9.25% Senior Notes due 2031 (issued July 2025 at 7.5% coupon)

Investment Access

Public stock (NYSE/LSE). Private fund (Alternative Income Fund II, $303M, closed — not open to new investors)

Visual Summary

Burford Capital Financial Performance — FY2022 to FY2025

AltStreet-verified figures from primary SEC 10-K filings. All USD millions.

FY2022 Revenue

$319.2M

FY2022 Net Income (BUR shareholders)

$30.5M

FY2022 Realizations (cash proceeds)

$387.8M

FY2022 EPS Basic

$0.14

FY2023 Revenue

$1,086.9M (elevated by YPF unrealized gains)

FY2023 Net Income (BUR shareholders)

$610.5M (not representative of normalized earnings)

FY2023 Realizations (cash proceeds)

$559.4M

FY2023 EPS Basic

$2.79

FY2024 Revenue

$546.1M

FY2024 Net Income (BUR shareholders)

$146.5M

FY2024 Realizations (cash proceeds)

$991.3M

FY2024 EPS Basic

$0.67

FY2024 Capital Provision Assets

$5,243.9M

FY2024 Total Assets

$6,175.0M

FY2024 Total Debt

$1,763.6M

FY2024 BUR Equity

$2,419.4M

FY2025 Revenue

$413.4M

FY2025 Net Income (BUR shareholders)

$62.6M

FY2025 Realizations

$710.5M

FY2025 Capital Provision Assets

$5,609.9M

FY2025 Cash & Equivalents

$566.4M

FY2025 Total Debt

$2,127.8M

ASWhat the financial trajectory reveals

  • The FY2023 net income of $610.5M is an outlier driven by YPF unrealized fair value gains — not representative of normalized earnings. FY2022 ($30.5M) and FY2025 ($62.6M) are more representative of what the business generates when large unrealized gains are absent.
  • Realizations are the correct metric for evaluating cash generation: $387.8M (2022), $559.4M (2023), $991.3M (2024), $710.5M (2025). The FY2024 peak reflects a favorable vintage resolution cycle; FY2025 normalization reflects fewer large case conclusions in the period.
  • Debt has grown significantly: $1.269B (FY2022) → $1.534B (FY2023) → $1.764B (FY2024) → $2.128B (FY2025). The July 2025 $500M senior notes at 7.5% — the highest coupon in Burford's history — reflects both market conditions and the company's continued capital needs.
  • The YPF concentration trend (42% FY2024 → 46% FY2025) moved in the wrong direction before the March 2026 reversal. A well-diversified portfolio should be declining in single-case concentration over time, not increasing.

Key Gaps & Non-Disclosures

  • YPF Q1 2026 fair value impact from the Second Circuit reversal is not in any filed document as of May 2026 — the quantified impact will first appear in the Q1 2026 10-Q. The FY2025 10-K filed February 26, 2026 predates the March 27, 2026 ruling.
  • ICFR material weakness remediation status for FY2025 is not yet disclosed — the FY2025 10-K will confirm whether the weakness was remediated as of December 31, 2025.
  • Vintage year performance cohort analysis is not systematically disclosed — cumulative ROIC/IRR commingles all concluded matters since 2009.

Investor Operations

The practical questions investors actually care about: when tax documents arrive, how cash distributions work, and whether capital can be exited before the underlying asset is sold.

Tax Documents

K-1 Timing

What to expect

No K-1 expected for standard brokerage ownership of Burford common stock. US holders receive Form 1099-DIV, typically late-January to mid-February.

Delay signals

  • No K-1 applies — standard 1099-DIV brokerage timing.
  • Investors using non-standard custody or cross-border accounts should confirm timing with their brokerage or tax adviser.

Cash Flow

Distributions

Frequency

Semi-annual — one interim dividend (approximately August/September) and one final dividend (approximately February/March) each year.

Timing

Paid through brokerage account on standard public-equity payable dates. FY2025 example: interim dividend paid December 4, 2025; proposed final dividend record date May 22, 2026, pay date June 12, 2026.

Consistency

$0.125/share annually (two payments of $0.0625) consistently across FY2022, FY2023, FY2024, FY2025. Final dividends subject to shareholder approval under Guernsey law. Board suspended dividends during COVID 2020; restored 2021.

Liquidity

Exit Reality

Holding period

No lockup — daily exchange liquidity on NYSE and LSE.

Exit options

  • Sell NYSE- or LSE-listed BUR shares through any standard brokerage account during market hours
  • Board-authorized share repurchase programs return capital through open-market buybacks — not shareholder redemption rights
  • No Burford-operated redemption queue, tender program, or private secondary mechanism for ordinary public shareholders

Secondary market

Full secondary market liquidity via NYSE and LSE. No proprietary redemption mechanism. Stock price may diverge from intrinsic value for extended periods — 2019 Muddy Waters short-seller attack crashed stock before recovery is the canonical example. YPF reversal creates near-term price uncertainty.

Confidence: High

Investment Structures

Public Common Stock — NYSE/LSE: BUR

The primary and only retail-accessible vehicle. Purchase through any brokerage supporting NYSE or LSE trading.

Provides diversified equity exposure to Burford's full litigation finance portfolio across 100+ active matters and three business segments (Principal Finance, Asset Management, auxiliary services). No lockup — daily exchange liquidity.

Returns through stock appreciation plus board-declared dividends ($0.125/share annually, semi-annual cadence, FY2022–FY2025). Fair value accounting produces quarterly earnings volatility unrelated to cash generation.

Shareholder rights include voting on major corporate matters, annual report review, and dividend approval (final dividend requires shareholder vote under Guernsey law). No case-level transparency or individual investment selection..

Alternative Income Fund II LP — Closed, Institutional Only

Private closed-end fund raising $303M from 7 institutional investors (avg $43.3M check) via Rule 506(b), first sale May 2022. No amendments filed — single institutional close.

No minimum stated (institutional direct placement). Not open to new investors.

CIK 0001930272. This vehicle provided institutional LPs direct exposure to Burford's lower-risk legal finance strategy separate from the public company balance sheet.

The Opportunity Fund series (LP, B LP, Feeder Fund, Employee Feeder) and Alternative Income Fund LP/Feeder are all pre-open at $0 Reg D — institutional capital raised outside Reg D..

Risk

Risk Structure

This is where the marketplace pitch gives way to the actual operating reality: delayed exits, limited disclosure, fee drag, and path-dependent outcomes.

YPF Concentration and March 2026 Second Circuit Reversal

YPF-related assets represented 46% of capital provision assets as of December 31, 2025 ($2.6B fair value). The March 27, 2026 Second Circuit reversal in the YPF nationalization case materially undermined the fair value basis for these assets — the case won at district court in 2023 generating $543M unrealized gains, but the appellate reversal effectively resets the risk profile of the largest single position in the portfolio. The quantified Q1 2026 fair value impact is not yet disclosed. A 46% concentration in a single appellate matter is the most material near-term risk in the stock.

Unremediated Material Weakness in ICFR

Burford disclosed a material weakness in internal controls over financial reporting specifically affecting the fair value measurement of capital provision assets — first disclosed in the FY2023 Form 20-F, still unremediated as of December 31, 2024 per the FY2024 10-K. KPMG (the new auditor) confirmed the material weakness. The weakness relates to the precision of management's review controls for the assumptions used in fair value estimation of litigation assets. No misstatements resulted. Remediation measures were implemented during FY2024 but had not operated for sufficient time to be considered effective. FY2025 remediation status is not yet disclosed.

Fair Value Accounting Disconnect

Burford's litigation portfolio is marked to fair value quarterly using Level 3 unobservable inputs (discounted cash flow, risk-adjusted probability factors, management estimates of case outcomes). This creates significant quarterly earnings volatility unrelated to cash generation — FY2023 net income of $610.5M reflects primarily YPF unrealized gains, not cash received; FY2025 net income of $62.6M reflects fewer favorable case events. Cash realizations ($710.5M in FY2025) are a more reliable indicator of business performance than GAAP net income. Investors who react to quarterly GAAP results without understanding fair value mechanics will systematically misread the business.

Auditor Change — EY to KPMG, July 2024

EY was dismissed effective immediately after the Q2 2024 financial statements; KPMG was appointed the same day. Mid-year auditor transitions are unusual for public companies and warrant investor awareness. Both EY and KPMG consents appear in the FY2024 10-K, with EY covering through H1 2024 and KPMG covering H2 2024 and FY2024 year-end. The transition occurred during the same period as the unremediated ICFR weakness — the timing does not imply causation but the coincidence is worth noting.

Leverage and Capital Markets Dependency

Burford's debt has grown from $1.27B (FY2022) to $2.13B (FY2025). The July 2025 $500M senior notes at 7.5% represent the highest coupon in company history. The business requires continuous capital market access to maintain $400M+ annual deployment — any disruption to debt or equity issuance capacity constrains growth and potentially forces suboptimal portfolio decisions. Net debt at approximately 22% of tangible assets is manageable but rising.

YPF Concentration — The Defining Near-Term Risk

Risk Summary

YPF-related assets at 46% of capital provision assets as of December 31, 2025. March 27, 2026 Second Circuit reversal creates material Q1 2026 fair value headwind. FY2023 income was elevated by ~$1.3B YPF unrealized gains; those gains are now under threat.

Why It Matters

At 46% portfolio concentration, the YPF case is no longer a single position — it is effectively the primary driver of the portfolio's reported fair value. A single appellate ruling changes the investment thesis for the entire company. The March 2026 reversal does not necessarily mean zero recovery (enforcement options remain), but it materially extends the expected resolution timeline and increases outcome uncertainty.

Mitigation / Verification

Review the Q1 2026 10-Q when filed for the quantified fair value impact of the reversal. Burford has stated it has multiple enforcement avenues for the YPF case. The critical questions: (1) what is the revised fair value of YPF assets as of March 31, 2026? (2) what is management's revised timeline and recovery probability? (3) does the reversal affect the company's debt covenants?

Material Weakness — Verification Gap on Core Asset Valuation

Risk Summary

Unremediated ICFR weakness over fair value measurement of capital provision assets. The very assets that drive reported earnings cannot be independently verified through the internal controls that are supposed to exist for exactly that purpose.

Why It Matters

Fair value of litigation assets is Burford's primary balance sheet item ($5.6B as of December 31, 2025) and the primary driver of quarterly earnings. An internal control weakness specifically affecting the precision of management's review of the assumptions underlying those valuations means that the reported fair values cannot be independently verified through internal controls. Management asserts no misstatements resulted — that assertion is difficult to independently validate given the weakness in the verification mechanism.

Mitigation / Verification

Verify remediation status in FY2025 10-K (filed February 26, 2026). If remediated, the risk is historical. If still unremediated, escalate scrutiny of all reported fair values and consider waiting for FY2025 audit completion before establishing or adding to a position.

Litigation Timing Unpredictability

Risk Summary

Typical 3–7 year case duration with significant variance. COVID-19 delayed 43% of portfolio 1–2 years. Complex international arbitrations can extend 10+ years. Realization timing depends on trial calendars, judicial assignments, and defendant strategy.

Why It Matters

Extended durations reduce IRR even if ultimate ROIC is unchanged. Capital deployed in 2020–2021 may not realize until 2027–2029 or later. Company must continuously raise new capital to maintain deployment pace during realization droughts — increasing leverage and interest costs during quiet periods.

Mitigation / Verification

Public stock provides daily liquidity unlike private litigation funds. Model returns using IRR not just ROIC to account for duration. Review realization velocity trends across quarterly filings — sustained decline below $500M quarterly annualized would signal duration extension pressures.

Competition Intensifying as Industry Matures

Risk Summary

Private equity firms, hedge funds, and new litigation finance entrants competing for same deal flow. Pricing pressure as multiple funders bid on attractive cases. Law firms building internal expertise reducing information asymmetry.

Why It Matters

Returns may compress over time as the industry matures from early opportunistic phase to efficient market. Historical ROIC/IRR figures reflect 2009–2015 first-mover advantage that is structurally harder to replicate. Recent vintage performance data (not systematically disclosed) would be the most useful indicator of whether returns are compressing.

Mitigation / Verification

Monitor new commitment volumes and new commitment ROIC (when disclosed). Burford's scale, brand, and proprietary case database represent genuine competitive advantages. But request vintage-year IRR breakdowns when engaging management.

ASRisk signals to watch

  • Q1 2026 10-Q (expected May 2026) — quantified YPF fair value impact from Second Circuit reversal is the single most important near-term disclosure
  • FY2025 10-K ICFR remediation assessment — confirms whether material weakness was resolved as of December 31, 2025
  • Debt covenant compliance as YPF fair value declines — any covenant triggered by portfolio fair value reduction would create refinancing pressure
  • New commitment volume and pricing in quarterly filings — leading indicator of competitive pressure and origination quality
  • Realization velocity — quarterly realizations below $150M annualized would signal portfolio duration extension

Regulatory & Legal Posture

Security Status

Public common stock trading on New York Stock Exchange (NYSE: BUR) and London Stock Exchange (LSE: BUR). Burford Capital Ltd (CIK 0001714174) is a domestic filer as of January 1, 2025, subject to 10-K/10-Q reporting. Commission file number: 001-39511.

Burford is incorporated in Guernsey but dual-listed on major US and UK exchanges. Transitioned from Foreign Private Issuer (20-F) to domestic filer (10-K/10-Q) effective January 1, 2025, moving to quarterly SEC reporting.

Shareholders own equity in the operating company rather than direct litigation claims. NYSE/LSE listing provides investor protections, audited financials, and regulated disclosure unavailable in private litigation finance.

Guernsey parent qualifies for local income tax exemption annually..

Disclosure Quality

Quarterly and annual reporting provide segmented results for Principal Finance and Asset Management segments, plus commitments, deployments, realizations, cash receipts, portfolio carrying values, and cumulative ROIC/IRR statistics. US GAAP accounting since at least FY2022 (earlier disclosures on IFRS). Limited case-level detail due to confidentiality and competitive concerns. Fair value methodology disclosed at methodology level but not at individual case level. Material weakness in ICFR over fair value measurement unremediated as of December 31, 2024 — reduces confidence in reported quarterly valuations.

Custody Model

Shares held in brokerage accounts via DTC (US investors) or CREST (UK investors). Litigation portfolio assets held directly by Burford operating subsidiaries. No third-party custodian for underlying legal claims.

Regulatory Backing

SIPC coverage for US brokerage accounts up to $500K (protects against broker insolvency, not market losses). FSCS coverage for UK brokers.

No FDIC insurance. Shareholders have creditor rights in bankruptcy but subordinate to $2.1B+ senior notes outstanding.

KPMG LLP provides annual audit; material weakness in fair value ICFR unremediated as of FY2024..

Tax Treatment

Reporting

1099-DIV (US shareholders receiving dividends); Schedule D for stock sale gains/losses

US shareholders receive Form 1099-DIV through their broker rather than a Schedule K-1. Delivery typically late-January to mid-February following year-end. Stock sale gains/losses handled through standard brokerage reporting and Schedule D. No K-1 complexity for ordinary public stock ownership.

Income Character

Qualified dividends (15–20% long-term capital gains rate for US holders); stock sales produce short-term or long-term capital gains depending on holding period

Dividends from Burford are generally qualified dividend income eligible for favorable long-term capital-gains rates if the investor satisfies applicable holding-period rules and Burford continues to qualify as a qualified foreign corporation. Guernsey does not impose local withholding tax on dividends to non-resident shareholders — investors receive the declared dividend gross.

Stock sales produce capital gains: short-term (≤1 year, taxed as ordinary income) or long-term (>1 year, taxed at 15–20%). Burford's current management view is that the company is not a PFIC, avoiding Form 8621 and punitive PFIC treatment — but PFIC status is monitored annually and could change..

Limitation

Dividends are not guaranteed — board suspended payments during COVID 2020, restored 2021 at $0.125/share annually. Final dividends require shareholder approval under Guernsey law. PFIC status monitored annually — any change would significantly affect US holder tax treatment. Wash sale rules apply if selling at loss and repurchasing within 30 days.

Special Considerations

UBTI Risk

No UBTI concern for pure public equity ownership. IRA investors can hold BUR without UBTI exposure.

  • Qualified foreign corporation status should be verified annually — loss of QFC status would convert dividend treatment from qualified to ordinary income rates.
  • Cross-border investors should verify withholding tax treatment in their jurisdiction — Guernsey has no withholding, but treaty positions vary.
  • Stock volatility may create capital losses in years the company generates strong underlying returns if market reprices shares on YPF or accounting news.

Account Suitability

Taxable

Suitable — qualified dividends and long-term capital gains receive favorable tax treatment; no K-1 complexity; losses can offset gains.

Roth IRA

Suitable — gains and dividends grow tax-free; particularly attractive for long-term holders expecting substantial stock appreciation; no UBTI concerns.

Traditional IRA

Suitable — dividends and gains accumulate tax-deferred; distributions taxed as ordinary income in retirement; no UBTI concerns; RMDs apply at age 73+.

HSA

Suitable — tax-advantaged growth for long-term holders; verify HSA custodian permits individual stock holdings.

Before You Invest

Get Burford Capital investor insights before you invest

K-1 timing, distribution updates, yield insights, and risk signals for Burford Capital and similar platforms.

  • Weekly platform research focused on tax timing and liquidity reality.
  • Signals on distributions, risks, and structural tradeoffs before capital is locked up.
  • Coverage of adjacent platforms so you can compare better options faster.

Get weekly platform signals

Track fee changes, liquidity updates, risk flags, and adjacent platforms before you invest.

Independent intelligence from AltStreet. No hype. No sponsor spin.

AS

AltStreet Data Layer

What the data actually shows

AltStreet tracks FY2022–FY2025 annual performance for Burford Capital from primary 10-K SEC filings and one EDGAR Form D exit record. These are the five findings most relevant for underwriting the current investment.

Warning

YPF concentration increased, not decreased, in FY2025

YPF-related assets as percentage of capital provision assets: 42% at December 31, 2024 → 46% at December 31, 2025. Despite portfolio growth from $5.244B to $5.610B, YPF concentration increased. The March 27, 2026 Second Circuit reversal hits a position that was growing as a share of the portfolio, not shrinking.

What this means

A well-managed concentrated position should show declining concentration as other cases resolve and new capital is deployed. The increasing YPF share through FY2025 suggests either deliberate concentration or insufficient diversification via new deployments. Q1 2026 will show the fair value impact of the reversal against this elevated base.

Finding

FY2023 net income of $610.5M is an outlier — not the earnings baseline

FY2023 net income attributable to BUR shareholders: $610.5M. FY2022: $30.5M. FY2024: $146.5M. FY2025: $62.6M. The FY2023 spike was driven by approximately $1.3B in YPF-related unrealized fair value gains, not cash generation. Realizations (cash received): FY2023 $559.4M — lower than FY2024 ($991.3M) and FY2025 ($710.5M).

What this means

Investors evaluating Burford on GAAP net income will find FY2023 massively misleading. Realizations are the correct cash-generation metric. On realizations, FY2024 was the peak year ($991M) and FY2025 represents normalization ($710M). The YPF reversal creates further realization timing uncertainty.

Notable

Debt has grown 68% in three years — and at rising cost

Total debt: $1.269B (FY2022) → $1.535B (FY2023) → $1.764B (FY2024) → $2.128B (FY2025). July 2025 senior notes: $500M at 7.5% — the highest coupon in Burford's history. Interest expense: $78.3M (FY2022), $99.1M (FY2023), $135.6M (FY2024).

What this means

Rising debt at rising cost compresses the spread between portfolio returns and financing costs. At 26% IRR on concluded matters, Burford still earns well above its 7.5% cost of debt — but the cushion is narrowing as funding costs rise and if portfolio IRR compresses with industry maturation.

Warning

Auditor changed mid-year concurrent with ICFR material weakness

EY dismissed July 1, 2024 — effective immediately after Q2 2024 financials. KPMG appointed same day. Both firms' consents appear in FY2024 10-K. Material weakness over fair value measurement of capital provision assets first disclosed FY2023 (Form 20-F), unremediated FY2024 (Form 10-K). The auditor transition and the material weakness overlap in time.

What this means

The coincidence of a mid-year auditor change and an unremediated internal control weakness over the core asset valuation methodology warrants investor awareness. Neither individually constitutes evidence of misconduct — but together they create a period of reduced independent verification over the most critical estimates in the financial statements.

Finding

Alternative Income Fund II: $303M from 7 investors — no Reg D amendments

Burford Alternative Income Fund II LP (CIK 0001930272): single 506(b) filing, May 2022, $303M raised from 7 institutional investors (avg $43.3M check). No amendments filed. Six other Burford fund entities all pre-open at $0 Reg D — institutional capital raised outside Reg D requirements entirely.

What this means

The complete absence of retail investors from Burford's private fund vehicles — and the institutional average check of $43.3M — confirms that direct access to Burford's litigation finance economics (without public company overhead and fair value noise) is effectively unavailable below institutional scale. BUR public stock is the only accessible vehicle.

Data as of 2026-05-06 . AltStreet review evidence layer . Public-source analysis

Decision Fit

Investor Fit

Who this works for, who it does not, and what level of patience and complexity tolerance the platform really demands.

Sophisticated Long-Term Equity Investors

5 Year Minimum HorizonFair Value Accounting Literacy
+Well Suited

Well-suited for sophisticated investors seeking liquid alternative asset exposure with a 5–7 year horizon aligned with case realization cycles. Public stock provides daily liquidity unlike private litigation finance lockups.

15-year track record with institutional-grade underwriting is compelling. Requires genuine understanding of fair value accounting mechanics to avoid misinterpreting quarterly results..

Alternatives Allocators — Diversification Mandate

Accepts Concentrated Positions
+Well Suited

Strong fit for allocators seeking uncorrelated returns from commercial litigation outcomes. Burford's portfolio of 100+ commercial matters has historically shown low correlation to equity and credit markets.

YPF concentration at 46% is a current constraint on the diversification thesis — monitor for rebalancing in future periods..

Income Investors

Income Predictability Required
xPoor Fit

Poor fit. While Burford pays $0.125/share annually ($27M total), dividends are board-controlled, were suspended in 2020, and represent a small fraction of stock return potential.

Fair value accounting creates earnings volatility that bears no relationship to cash generation. Income investors who need predictable distributions should look elsewhere..

Short-Term Traders

Short Horizon
xPoor Fit

Poor fit. Case realization timing is inherently unpredictable.

Stock price may diverge from intrinsic value for extended periods. The YPF reversal creates near-term price uncertainty that is difficult to model.

Quarterly GAAP earnings are misleading without fair value accounting literacy..

Risk-Averse Investors

Low Volatility Required
xPoor Fit

Poor fit. YPF concentration, material weakness, fair value accounting volatility, and leverage create a risk profile that is not suitable for risk-averse allocators despite the strong long-term track record.

The 2019 Muddy Waters attack and the March 2026 YPF reversal are both examples of the binary event risks embedded in the stock..

Tradeoffs

Key Tradeoffs

The attraction of pre-IPO access is real, but every benefit comes bundled with a corresponding liquidity, transparency, or pricing cost.

1

Liquidity vs. Case Concentration

Public stock provides daily NYSE/LSE liquidity that no private litigation fund can match. But with 46% of the portfolio in YPF assets after the March 2026 reversal, liquidity does not eliminate the binary outcome risk inherent in a single appellate matter representing nearly half the portfolio..

2

Track Record vs. Current Vintage

The 15-year 83% cumulative ROIC and 26% IRR figures are real and audited. They also commingle early first-mover vintages (2009–2015) with recent vintages in a more competitive market.

Whether recent vintage performance matches the historical average is not disclosed — this is the most important unknown for underwriting future returns..

3

Fair Value Transparency vs. Quarterly Noise

US GAAP fair value accounting provides quarterly portfolio marks that private funds do not. But those marks are derived from Level 3 unobservable inputs (management estimates), subject to a material ICFR weakness, and produce earnings that bear no predictable relationship to cash generation.

The transparency creates noise, not clarity..

4

Scale vs. Governance

Burford's $7.5B portfolio and 45+ lawyer team provide institutional-grade case selection and enforcement capabilities. Public shareholders have no influence over case selection, portfolio construction, or risk management.

The governance tradeoff is total: professional management in exchange for zero investor input..

5

Public Access vs. Private Fund Economics

BUR stock is accessible to any brokerage investor with no minimum or accreditation requirement. The Alternative Income Fund II — the institutional private fund product — required $43M average check size and is now closed.

The economics of the public stock and the private fund are structurally different..

Avoid

Who This Is Not For

This section should be read as a filter, not an afterthought. If you need income, simplicity, or near-term access to capital, the structure is working against you.

Investors Expecting Predictable Quarterly Income

Fair value accounting produces quarterly earnings entirely disconnected from cash generation. FY2023 net income of $610.5M and FY2025 net income of $62.6M are from the same business in consecutive periods — the difference is unrealized fair value movements, not cash..

Investors Who Need Case-Level Transparency

Public shareholders cannot review individual case details, underwriting memos, or specific risk factors. No ability to select specific litigation matters or conduct independent diligence on individual positions.

The entire portfolio is a black box outside of aggregate statistics..

Investors Who Cannot Tolerate Binary Event Risk

YPF at 46% of capital provision assets means the portfolio is effectively a concentrated bet on a single appellate matter. The March 2026 Second Circuit reversal demonstrates that binary events can materially impair fair value in a single ruling.

This is not a diversified alternatives position in its current state..

Investors Who Need Auditor Certainty on Core Asset Values

The unremediated material weakness in ICFR over fair value measurement specifically affects the controls verifying the assumptions underlying litigation asset valuations. If independently verifiable fair value certification is required, FY2025 remediation status should be confirmed before investing..

Editorial View

AltStreet Perspective

The compressed version of the review: what matters, what marketing tends to obscure, and how we would frame the platform for a serious allocator.

Verdict

Burford is the most credible public access point to commercial litigation finance and its 15-year track record is genuine. The combination of 83% cumulative ROIC, 93% recovery rate, and $3.8B lifetime realizations across a diversified portfolio of commercial disputes represents institutional-grade underwriting quality that no retail platform can match. The near-term picture is more complicated: 46% YPF concentration after an appellate reversal, an unremediated ICFR material weakness, rising debt costs, and declining realizations ($710M in FY2025 vs $907M in FY2024) create a specific set of risks that need explicit investor acceptance before buying. BUR is not a low-volatility alternatives position — it is a leveraged, concentrated, long-duration equity position in a complex underwriting business that happens to trade daily on a stock exchange.

Positioning

AltStreet covers Burford as the institutional benchmark for evaluating all retail litigation finance platforms. The questions we ask of LexShares, Legalist, and any other platform — carry structure, IRR methodology, loss rate transparency, duration assumptions — are answered by Burford with more rigor and disclosure than any private alternative. The comparison is instructive: LexShares raised $125M, marketed 47% IRR, and is now in harvest mode at approximately 4% fund-level trajectory. Burford raised $3.8B, reports 26% IRR on concluded matters, and continues to deploy at scale. The institutional infrastructure matters. So does the YPF concentration.

The Bottom Line

The institutional benchmark for litigation finance — fifteen years, $3.8B in realizations, and a 46% YPF concentration that the Second Circuit just made materially more complicated.

Action

Next Steps

If you still want to engage after reading the review, these are the practical next moves that reduce avoidable mistakes.

1

Read the Q1 2026 10-Q (expected May 2026) before initiating or adding to a position — it will contain the quantified YPF fair value impact from the March 27, 2026 Second Circuit reversal.

2

Verify FY2025 ICFR remediation status in the FY2025 10-K (filed February 26, 2026) — if the material weakness is remediated, that removes a significant governance concern.

3

Model returns using cumulative cash realizations, not GAAP net income — FY2023's $610.5M net income is an accounting artifact, not representative of cash generation capacity.

4

Monitor the YPF enforcement proceedings following the reversal — Burford has stated multiple enforcement avenues remain; the pace and probability of those proceedings will drive the most material fair value movements in 2026.

5

Compare BUR against Legalist and other active litigation finance platforms using the four questions from the LexShares framework: carry structure, IRR methodology, loss rate, and actual vs. underwritten hold period.

AltStreet Weekly

We track exit data others don't

Join the AltStreet newsletter for verified exits, fee friction, liquidity signals, and side-by-side platform analysis as new reviews go live.

No spam. Just alternative-investment research when it is useful.

Get weekly platform data

Appendix

Sources, Disclosures, and Supporting Context

The lower section is structured like a report appendix: relationship context first, adjacent reading second, and evidence last.

Report Appendix

Disclosure

Relationship and compensation context

+
Relationship Disclosure: AltStreet has no financial relationship or compensation arrangement with Burford Capital Limited or any of its affiliated entities. This review is based on publicly available SEC filings (10-K FY2024, 10-K FY2025), EDGAR Form D filings for all Burford fund entities, burfordcapital.com public content, shareholder research, and third-party press reporting. All financial data verified from primary 10-K source documents.

Report Appendix

Related Resources

Adjacent platform comparisons, frameworks, and category links

+

Further Reading

Related Resources

Adjacent frameworks and reviews that help place the platform in a broader allocation or due-diligence context.

Similar Platform Reviews

  • LexShares

    Retail litigation finance platform — now in harvest mode. The gap between LexShares' marketed 47% IRR and actual fund-level trajectory is the essential context for evaluating Burford's own performance claims.

  • Legalist

    Active algorithmic litigation finance platform. Smaller scale, different underwriting approach. Apply the same carry structure and IRR methodology framework from the LexShares analysis.

Report Appendix

Evidence & Methodology

Sources, scope, and how the review was assembled

+

ASReview Evidence

Data as of2026-05-06

Methodology

Primary 10-K filings for FY2024 (filed March 3 2025, accession 0001714174-25-000055) and FY2025 (filed February 26 2026). FY2022 and FY2023 data from comparative periods in the FY2024 10-K. EDGAR Form D filings for 8 Burford-related entities (CIKs 0001714174, 0001930272, 0001714257, 0001760018, 0001760019, 0001760024, 0001760025, 0001760326, 0001760463). Financial data extracted and stored in platform_performance_history via ingestPublicFilings.ts.

Scope

FY2024 10-K (656K chars, 4 relevant section chunks extracted) + FY2025 10-K (extracted high confidence) + 8 EDGAR Form D entity searches + burfordcapital.com public content + shareholder research on tax/dividend mechanics

Key Findings

  • *AltStreet extracted FY2022–FY2025 performance history from primary 10-K filings using ingestPublicFilings.ts — revenue, net income, realizations, total assets, cash, equity verified from primary source documents.
  • *Auditor change confirmed from 10-K Item 9: EY dismissed July 1, 2024 effective immediately after Q2 2024 financials; KPMG appointed same day. Both consents in FY2024 10-K.
  • *Material weakness confirmed from 10-K Item 9A: unremediated ICFR weakness over fair value measurement of capital provision assets as of December 31, 2024. First disclosed FY2023 Form 20-F.
  • *YPF concentration trajectory verified: 42% (FY2024) → 46% (FY2025) from Notes to Financial Statements capital provision asset breakdowns.
  • *EDGAR Form D for Burford Capital LLC (CIK 0001714257) confirmed as nonqualified deferred compensation plan — not an investor offering. Six pre-open fund entities confirmed at $0 Reg D capital.

Primary Source Pages

SEC EDGAR CIK 0001714174 — Burford Capital Ltd (10-K, 10-Q filer)
2024 Form 10-K: Consolidated Statements of Operations (FY2022, FY2023, FY2024 comparative)
2024 Form 10-K: Consolidated Statements of Financial Condition (FY2023, FY2024)
2024 Form 10-K: Note 5 (Capital Provision Assets movements)
2024 Form 10-K: Item 9A (Material Weakness — ICFR unremediated)
2024 Form 10-K: Item 9 (Auditor change EY → KPMG, July 1 2024)
2024 Form 10-K: Note 12 (Debt — $1.763B outstanding)
2025 Form 10-K (filed February 26 2026) — FY2025 primary period data
SEC EDGAR CIK 0001930272 — Burford Alternative Income Fund II LP Form D ($303M, 7 investors, May 2022)
SEC EDGAR CIK 0001714257 — Burford Capital LLC Form D (deferred compensation plan — not investor offering)
burfordcapital.com — corporate overview, case descriptions, investor materials

Comparable Platforms

  • LexShares

    Retail litigation finance platform now in harvest mode. Provides the essential baseline for evaluating Burford's IRR methodology and carry structure claims against actual retail outcomes.

  • Legalist

    Active algorithmic litigation finance platform. Smaller scale, different underwriting approach. Comparable category for fee structure and IRR methodology evaluation.

FAQ

Frequently Asked Questions

High-intent search questions answered directly, without making users hunt through the full review.

Q

What is Burford Capital and how does it make money?

Burford provides capital to fund commercial lawsuits and arbitrations in exchange for a percentage of recoveries. Company finances legal fees, expert costs, and expenses for corporations and law firms. Makes money when cases win or settle favorably, receiving agreed share of proceeds. Loses investment if case unsuccessful. Investors access through public stock (NYSE/LSE: BUR) — not direct case participation.

Q

What are Burford's historical returns?

83% cumulative ROIC and 26% IRR on concluded capital provision-direct matters since inception per FY2025 10-K disclosure. Approximately $3.8B in lifetime realizations. FY2024 concluded matters: 87% ROIC. These figures include outlier mega-cases (YPF, Akhmedov) and reflect a 15-year period including early first-mover advantage. Future returns may be lower or lumpier.

Q

What happened with YPF and why does it matter?

YPF-related assets represent 46% of Burford's capital provision portfolio as of December 31, 2025. The district court ruled in Burford's favor in 2023, generating approximately $1.3B in unrealized fair value gains that elevated FY2023 net income. On March 27, 2026, the Second Circuit reversed that judgment, creating a material Q1 2026 fair value headwind. The Q1 2026 10-Q will contain the quantified impact — not yet disclosed as of May 2026.

Q

What is the material weakness Burford disclosed?

Burford disclosed an internal control weakness over the fair value measurement of capital provision assets — first in its FY2023 Form 20-F, still unremediated as of December 31, 2024 per the FY2024 10-K. The weakness relates to the precision of management's review controls for the assumptions underlying litigation asset valuations. Management states no misstatements resulted. KPMG confirmed the weakness in its attestation report.

Q

Why did Burford change auditors from EY to KPMG?

EY was dismissed effective July 1, 2024 — immediately after the Q2 2024 financial statements. KPMG was appointed the same day for Q3 2024 through FY2024. Both firms' consents appear in the FY2024 10-K. Burford reported the change via Form 6-K on July 9, 2024. The transition coincided with an unremediated material weakness in internal controls — the timing warrants investor awareness though no causal connection has been established.

Q

How does Burford's stock work as a litigation finance investment?

Buying BUR gives you equity exposure to Burford's entire litigation finance portfolio — not direct ownership of individual cases. Returns come from stock appreciation and dividends ($0.125/share annually). Fair value accounting produces quarterly earnings that often bear no relationship to cash generation. The correct metric to follow is realizations: cash received from concluded cases ($710.5M in FY2025, $991.3M in FY2024).

Q

What are the main risks of investing in Burford?

Four specific near-term risks: (1) YPF concentration at 46% after the March 2026 Second Circuit reversal — most material near-term risk; (2) unremediated ICFR material weakness over core asset valuations; (3) rising debt load at increasing cost (7.5% coupon on July 2025 notes); (4) fair value accounting volatility that creates misleading quarterly earnings. Long-term risks include competition, regulatory change, and enforcement challenges on sovereign cases.

Q

How does Burford compare to private litigation finance platforms like LexShares?

LexShares raised $125M, marketed 47% median IRR, and is now in harvest mode tracking approximately 4% fund-level trajectory. Burford raised $3.8B in lifetime realizations, reports 26% IRR on concluded matters, and continues to deploy at scale with KPMG-audited financials. The institutional infrastructure — 45+ in-house lawyers, $7.5B portfolio, public company disclosure — makes Burford the benchmark against which all retail litigation finance platforms should be evaluated.

Q

Does Burford pay dividends?

Yes — $0.125 per share annually (two semi-annual payments of $0.0625), consistently paid in FY2022, FY2023, FY2024, and FY2025. Total annual dividends approximately $27M. Dividends were suspended during COVID 2020 and restored in 2021. Final dividends require shareholder approval under Guernsey law. Treat BUR as a total-return equity position, not an income vehicle.

Q

Who should invest in Burford Capital?

Sophisticated long-term equity investors (5–7 year horizon) seeking alternative asset exposure through liquid public equity who understand fair value accounting mechanics. NOT suitable for: income seekers expecting predictable distributions, short-term traders, investors requiring case-level transparency, risk-averse investors, or anyone who cannot tolerate binary event risk from the YPF concentration.